Lisbeth Harder

559 total citations
22 papers, 278 citations indexed

About

Lisbeth Harder is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Lisbeth Harder has authored 22 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Lisbeth Harder's work include Thyroid Disorders and Treatments (11 papers), Circadian rhythm and melatonin (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Lisbeth Harder is often cited by papers focused on Thyroid Disorders and Treatments (11 papers), Circadian rhythm and melatonin (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Lisbeth Harder collaborates with scholars based in Germany, Sweden and Australia. Lisbeth Harder's co-authors include Jens Mittag, Carolin S. Hoefig, Henrik Oster, Björn Vennström, Rebecca Oelkrug, Heike Heuer, Kornelia Johann, Nancy Schanze, Josef Köhrle and Lutz Schomburg and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Lisbeth Harder

22 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisbeth Harder Germany 11 110 76 74 60 34 22 278
Elina Akalestou United Kingdom 7 112 1.0× 129 1.7× 80 1.1× 56 0.9× 32 0.9× 12 384
Luis F. Soto Spain 9 88 0.8× 48 0.6× 130 1.8× 14 0.2× 31 0.9× 16 353
Petra Klusoňová Czechia 12 166 1.5× 58 0.8× 148 2.0× 13 0.2× 16 0.5× 26 384
Taylor Rice United States 9 36 0.3× 43 0.6× 158 2.1× 25 0.4× 16 0.5× 12 360
M. Hlinka United States 7 39 0.4× 137 1.8× 22 0.3× 122 2.0× 29 0.9× 11 324
Mohammad Fararjeh Jordan 5 40 0.4× 222 2.9× 26 0.4× 73 1.2× 31 0.9× 8 313
Pan Liu China 11 17 0.2× 80 1.1× 62 0.8× 19 0.3× 23 0.7× 35 302
E. Kokkotou United States 9 26 0.2× 68 0.9× 80 1.1× 101 1.7× 43 1.3× 10 327
Andreas Mykoniatis United States 9 48 0.4× 48 0.6× 87 1.2× 22 0.4× 78 2.3× 13 365
Yoko Koike Japan 12 46 0.4× 63 0.8× 107 1.4× 20 0.3× 36 1.1× 18 340

Countries citing papers authored by Lisbeth Harder

Since Specialization
Citations

This map shows the geographic impact of Lisbeth Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisbeth Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisbeth Harder more than expected).

Fields of papers citing papers by Lisbeth Harder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisbeth Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisbeth Harder. The network helps show where Lisbeth Harder may publish in the future.

Co-authorship network of co-authors of Lisbeth Harder

This figure shows the co-authorship network connecting the top 25 collaborators of Lisbeth Harder. A scholar is included among the top collaborators of Lisbeth Harder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisbeth Harder. Lisbeth Harder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harder, Lisbeth, Anja Traeger, Stephanie Hoeppener, et al.. (2025). Poly(2‐ethyl‐2‐oxazoline) (POx) as Poly(ethylene glycol) (PEG)‐Lipid Substitute for Lipid Nanoparticle Formulations. Small. 21(16). e2411354–e2411354. 8 indexed citations
2.
Koch, Christiane E., Undine Haferkamp, Violetta Pilorz, et al.. (2025). Regulation of hedonic feeding rhythms by circadian clocks in leptin-receptive neurons. Molecular Metabolism. 100. 102221–102221. 1 indexed citations
3.
Harder, Lisbeth, Sergio Marco Salas, Clara Muñoz‐Castro, et al.. (2025). Oligodendroglia vulnerability in the human dorsal striatum in Parkinson’s disease. Acta Neuropathologica. 149(1). 46–46. 1 indexed citations
4.
Assis, Leonardo Vinícius Monteiro de, Lisbeth Harder, José Thalles Lacerda, et al.. (2024). Tuning of liver circadian transcriptome rhythms by thyroid hormone state in male mice. Scientific Reports. 14(1). 640–640. 7 indexed citations
5.
Harder, Lisbeth, Sergio Marco Salas, Mats Nilsson, et al.. (2024). Interneuron diversity in the human dorsal striatum. Nature Communications. 15(1). 6164–6164. 10 indexed citations
6.
Assis, Leonardo Vinícius Monteiro de, et al.. (2024). Thyroid hormone receptor beta (THRB) dependent regulation of diurnal hepatic lipid metabolism in adult male mice. SHILAP Revista de lepidopterología. 2(1). 21–21. 2 indexed citations
7.
Oelkrug, Rebecca, Lisbeth Harder, Anne Hoffmann, et al.. (2023). Maternal thyroid hormone receptor β activation in mice sparks brown fat thermogenesis in the offspring. Nature Communications. 14(1). 6742–6742. 6 indexed citations
8.
Assis, Leonardo Vinícius Monteiro de, Lisbeth Harder, José Thalles Lacerda, et al.. (2022). Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation. eLife. 11. 13 indexed citations
9.
Johann, Kornelia, Lisbeth Harder, Eva K. Wirth, et al.. (2020). CD5L Constitutes a Novel Biomarker for Integrated Hepatic Thyroid Hormone Action. Thyroid. 30(6). 908–923. 11 indexed citations
10.
Harder, Lisbeth, Rebecca Oelkrug, Jiesi Chen, et al.. (2020). Central Hypothyroidism Impairs Heart Rate Stability and Prevents Thyroid Hormone-Induced Cardiac Hypertrophy and Pyrexia. Thyroid. 30(8). 1205–1216. 16 indexed citations
11.
Harder, Lisbeth & Henrik Oster. (2020). The Tissue Clock Network: Driver and Gatekeeper of Circadian Physiology. BioEssays. 42(5). e1900158–e1900158. 17 indexed citations
12.
Jerome, H. Kim, Vattipally B. Sreenu, Tetyana Klymenko, et al.. (2019). Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers. Journal of Infection. 79(4). 383–388. 48 indexed citations
13.
Harder, Lisbeth & Henrik Oster. (2019). Zirkadiane Rhythmen – Wie beeinflussen sie unser Leben?. DMW - Deutsche Medizinische Wochenschrift. 144(15). 1014–1017. 2 indexed citations
14.
Johann, Kornelia, et al.. (2018). Effects of sildenafil treatment on thermogenesis and glucose homeostasis in diet-induced obese mice. Nutrition and Diabetes. 8(1). 9–9. 28 indexed citations
15.
Johann, Kornelia, Lisbeth Harder, Beatrice Engelmann, et al.. (2018). Identification of new thyroid hormone dependent biomarkers for a successful replacement therapy. Endocrine Abstracts. 1 indexed citations
16.
Harder, Lisbeth, Helge Müller‐Fielitz, Jens Hjerling‐Leffler, et al.. (2018). Maternal thyroid hormone is required for parvalbumin neurone development in the anterior hypothalamic area. Journal of Neuroendocrinology. 30(3). e12573–e12573. 23 indexed citations
17.
Oelkrug, Rebecca, Lisbeth Harder, Christiane E. Koch, et al.. (2017). Dwarfism and insulin resistance in male offspring caused by α1-adrenergic antagonism during pregnancy. Molecular Metabolism. 6(10). 1126–1136. 3 indexed citations
18.
Harder, Lisbeth, Nancy Schanze, Josef Köhrle, et al.. (2017). In vivo Effects of Repeated Thyronamine Administration in Male C57BL/6J Mice. European Thyroid Journal. 7(1). 3–12. 11 indexed citations
19.
Renko, Kostja, Carolin S. Hoefig, Corinne Dupuy, et al.. (2016). A Nonradioactive DEHAL Assay for Testing Substrates, Inhibitors, and Monitoring Endogenous Activity. Endocrinology. 157(12). 4516–4525. 20 indexed citations
20.
Hoefig, Carolin S., Amy Warner, Lisbeth Harder, et al.. (2015). 3‐Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo. British Journal of Pharmacology. 172(13). 3426–3433. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elina Akalestou Breakdown of academic impact, for papers by Luis F. Soto Breakdown of academic impact, for papers by Petra Klusoňová Breakdown of academic impact, for papers by Taylor Rice Breakdown of academic impact, for papers by M. Hlinka Breakdown of academic impact, for papers by Mohammad Fararjeh Breakdown of academic impact, for papers by Pan Liu Breakdown of academic impact, for papers by E. Kokkotou Breakdown of academic impact, for papers by Andreas Mykoniatis Breakdown of academic impact, for papers by Yoko Koike
Rankless by CCL
2026